1. Home
  2. NEWS
  3. Viron's CEO unveils Viron C1, an anti-COVID-19 nasal spray

Viron's CEO unveils Viron C1, an anti-COVID-19 nasal spray

Viron's CEO unveils Viron C1, an anti-COVID-19 nasal spray

December 17, 2021

Porosome Therapeutics, Inc., Chairman, Prof. Dr. Bhanu P. Jena and Chairman of the Scientific Advisory Board, Prof. Dr. Joachim Frank have been invited to participate at the Nobel Prize Dialogue being held in Seoul, South Korea on September 24th 2023.
Porosome Therapeutics, Inc. Files Comprehensive Patent for New Generation of Treatments for Cystic Fibrosis and Other Diseases
Porosome Therapeutics is the new name of Viron.